SPY312.18+4.10 1.33%
DIA263.17+5.32 2.06%
IXIC9,682.91+74.54 0.78%

Vir Biotechnology Q1 EPS $(0.710) Misses $(0.530) Estimate, Sales $5.718M Beat $2.920M Estimate

Vir Biotechnology (NASDAQ:VIR) reported quarterly losses of $(0.710) per share which missed the analyst consensus estimate of $(0.530) by 33.96 percent. This is a 77.74 percent increase over losses of $(3.190) per share

Benzinga · 05/12/2020 20:03

Vir Biotechnology (NASDAQ:VIR) reported quarterly losses of $(0.710) per share which missed the analyst consensus estimate of $(0.530) by 33.96 percent. This is a 77.74 percent increase over losses of $(3.190) per share from the same period last year. The company reported quarterly sales of $5.718 million which beat the analyst consensus estimate of $2.920 million by 95.82 percent. This is a 56.19 percent increase over sales of $3.661 million the same period last year.